Key facts
- It has raised $56.6M; the latest was Later Stage VC ($18.0M) in Jun 2025.
- Notable investors include Beutler, China Cinda Asset Management.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Salubris Biomedical Engineering
- ·The full record, as it builds
Funding rounds
No funding rounds for Salubris Biomedical Engineering are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Salubris Biomedical Engineering
Provider and developer of cardiovascular disease solutions and supplier of cardiovascular medical instruments. The company focuses on developing cardiovascular related medicine and instruments, enabling patients to prevent and treat cardiovascular disease.
- Sector
- Healthcare
- HQ
- Shenzhen, China
- Founded
- 2009
- Website
- salubrismed.com/
- Ownership
- Privately Held (backing)
Salubris Biomedical Engineering doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Salubris Biomedical Engineering shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Salubris Biomedical Engineering in its N-PORT filings yet. We sweep new filings monthly.